The rising prevalence of unwanted pregnancies is boosting the global contraceptive drugs market. In a report, titled “Contraceptive Drugs Market Size, Share and Global Trend By Product Type (Oral, Injectable, Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs) and Geography Forecast till 2025” Fortune Business Insights identifies various factors enabling growth in the market. According to the report, the global contraceptive drugs market is anticipated to rise at 5.8% CAGR and reach a value of US$ 20,200.5 Mn by 2025 from US$ 13,097.7 Mn in 2017. Remarkably improving access to contraceptive pills around the world is a key factor propelling growth in this market.
Highlights of the Report:
- In-depth analysis of various insights, namely, Market trends, growth drivers, opportunities, and other related challenges.
- Comprehensive details of key market players, their core competencies, and Contraceptive Drugs Market share.
- The potency of suppliers and buyers to make better business decisions.
- Lists out the market size in terms of volume.
For more information in the analysis of this report, visit: https://www.globenewswire.com/news-release/2019/07/10/1880708/0/en/Contraceptive-Drugs-Market-Exhibits-5-8-CAGR-Driven-by-Rising-Awareness-among-Women-says-Fortune-Business-Insights.html
Key Players Operating in The Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Bayer AG
- Pfizer Inc.
- Janssen Global Services, LLC
- Teva Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Mylan N.V.
- Allergan Plc
- Agile Therapeutics
- Piramal Enterprises Ltd.
Rising Abortion Rates to Create Demand for Contraceptive Drugs
Under the Affordable Care Act (ACA) in the U.S., oral contraceptive pills are given free of cost to women in the U.S. Such regulations favor the growth of the contraceptive drugs market. Increasing government initiatives to reduce infant mortality due to early pregnancies will increase the demand for oral contraceptives. Contraceptive drugs not only help to control unwanted pregnancies but also reduce the number of abortion and complications associated with the procedure worldwide.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contraceptive-drugs-market-100063
As per the World Health Organization, there is an estimated 40 to 50 million abortions every year, corresponding to an approximate of 125,000 abortions per day. To avoid unwanted and unplanned pregnancies, an increasing number of women are opting for contraceptive drugs. This will, in turn, augment growth in the global market.
Contrary to this, the market for contraceptive drugs may face challenges posed by religious, ethical, and social barriers, especially in more conservative regions. Social taboos often discourage the use of contraceptive drugs among women, subsequently adversely impacting the overall market.
Detailed Table of Content:
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- 1 Fertility Statistics – Key Countries, 2017
- 2 New Product Launch
- 3 Pipeline Analysis
- 4 Regulatory Scenario – Key Countries
- 5 Recent Industry Developments – Partnerships, Mergers & Acquisitions
Global Market Analysis, Insights and Forecast, 2014-2025
More Trending Topics from Fortune Business Insights: